These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1570757)

  • 1. Posttransplantation bone disease.
    Katz IA; Epstein S
    J Bone Miner Res; 1992 Feb; 7(2):123-6. PubMed ID: 1570757
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton.
    Epstein S
    J Bone Miner Res; 1996 Jan; 11(1):1-7. PubMed ID: 8770690
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone disorders after organ transplantation.
    Goffin E; Devogelaer JP
    Transplant Proc; 2005; 37(6):2832-3. PubMed ID: 16182824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cyclosporine nephrotoxicity in rheumatoid arthritis.
    Pei Y
    J Rheumatol; 1996 Jan; 23(1):4-5. PubMed ID: 8838500
    [No Abstract]   [Full Text] [Related]  

  • 5. Criteria for use of cyclosporine in adult transplant recipients.
    Ninno MA; Davis SK
    Clin Pharm; 1993 Sep; 12(9):696-8. PubMed ID: 8306570
    [No Abstract]   [Full Text] [Related]  

  • 6. Posttransplantation bone disease.
    Cunningham J
    Transplantation; 2005 Mar; 79(6):629-34. PubMed ID: 15785362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and dental problems in the organ transplant patient.
    Seymour RA; Thomason JM; Ellis JS
    Dent Update; 1994 Jun; 21(5):209-12. PubMed ID: 7875351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For organ transplant recipients, cancer threatens long-term survival.
    Ross K
    J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is it possible to prevent kidney problems caused by immunosuppression?].
    Aitio ML
    Duodecim; 2000; 116(5):511-9. PubMed ID: 11787104
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact and management of hyperlipidemia posttransplantation.
    Fellström B
    Transplantation; 2000 Dec; 70(11 Suppl):SS51-7. PubMed ID: 11152232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
    Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
    Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo malignancy after solid organ transplantation in children.
    Debray D; Baudouin V; Lacaille F; Charbit M; Rivet C; Harambat J; Iserin F; Di Filippo S; Guyot C;
    Transplant Proc; 2009 Mar; 41(2):674-5. PubMed ID: 19328954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoarticular complications of organ transplantations].
    Meys E; Delmas PD
    Rev Prat; 1994 Feb; 44(4):459-62. PubMed ID: 8184262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: implication for accelerated vasculopathy by immunosuppressive therapy.
    Sata M; Walsh K
    Biochem Biophys Res Commun; 1999 Sep; 263(2):430-2. PubMed ID: 10491310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after liver transplantation: keep the end in mind.
    Bucuvalas JC; Campbell KM; Cole CR; Guthery SL
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S41-8. PubMed ID: 16819401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients.
    Preiksaitis JK
    Clin Infect Dis; 2004 Oct; 39(7):1016-23. PubMed ID: 15472855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of calcium-channel antagonists in solid organ transplantation.
    Huntress JD; Papadakos PJ
    New Horiz; 1996 Feb; 4(1):129-33. PubMed ID: 8689268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone disease after renal transplantation.
    Heaf JG
    Transplantation; 2003 Feb; 75(3):315-25. PubMed ID: 12589151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
    Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion].
    Li V; Molina L; Michallet M; Hostein J
    Gastroenterol Clin Biol; 1992; 16(1):29-36. PubMed ID: 1537479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.